Dr. Jeffrey DeClaire will be one of five surgeons in the world implanting the recently FDA Approved Vanguard XP Bi-Cruciate TKA in April.

This new knee preserves the ACL and will be a “game changer” in the world of orthopedics and knees.

DeClaire has been working with four other surgeons on this over the last three years.
During a live broadcast on April 3, one of DeClaire’s patients will be receiving one of the first Bi-cruciate TKAs in the world at Crittenton Hospital.

More information and registration here.

Dr. Jeffrey DeClaire